Medical News

RSS

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Self-disorders highly specific to schizophrenia spectrum

Self-disorders – also known as anomalous self-experiences – are highly specific to individuals with schizophrenia-spectrum disorders, Danish research indicates.

11 Feb 2014

U-shaped association between paternal age and bipolar risk

Having a father who is relatively young or old may increase a person’s risk of developing bipolar disorder, a study suggests.

11 Feb 2014

Surgeons now use minimally invasive robotic surgical system for Whipple procedure

The Whipple procedure, used to remove tumors from pancreatic cancer patients, is one of surgery's most extensive and challenging operations.

11 Feb 2014

New approach for reducing levels of toxic protein fragments associated with Huntington's disease

An innovative therapeutic strategy for reducing the levels of toxic protein fragments associated with Huntington's disease uses a new approach called exon skipping to remove the disease-causing component of the essential protein, huntingtin.

11 Feb 2014

St. Joseph's Hospital opens new $20 million Heart Institute

St. Joseph's Hospital entered the next era of cardiac care by opening a new $20 million Heart Institute on Feb. 10, 2014. St. Joseph's Hospital Heart Institute is one of the most advanced and comprehensive centers for cardiovascular medicine in Florida, performing more than 50,000 adult cardiac catheterizations. It is also has the only pediatric catheterization program in Hillsborough County.

11 Feb 2014

Athletic scholarships could lead to long-term health consequences, warns Loyola sports medicine physician

College athletes are putting themselves at risk for health problems that could persist long after they graduate, warns Loyola University Medical Center sports medicine physician Dr. Pietro Tonino.

11 Feb 2014

UAB's Continence and Urogynecology Care Clinics reaccredited with Center Of Excellence designation

The National Association For Continence has reaccredited the University of Alabama at Birmingham's Continence and Urogynecology Care Clinics as a Center of Excellence for Continence Care.

11 Feb 2014

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.

11 Feb 2014

ADM commits $25 million equity investment in Rennovia

Archer Daniels Midland Company and Rennovia, Inc. announced today that ADM has committed to a $25 million equity investment in the privately held company, which develops catalysts and processes for the cost-advantaged production of chemical products from renewable feedstocks.

11 Feb 2014

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Ario Pharma Ltd, the Cambridge biopharmaceutical company developing innovative new approaches to treat respiratory disease, announced today that it has commenced a Phase IIa study of its TRPV1 antagonist, XEN-0501, for the treatment and prevention of cough in patients with chronic obstructive pulmonary disease (COPD). Persistent cough in COPD and other respiratory conditions present as a huge unmet medical need, with novel therapies urgently needed to improve the quality of life of patients.

11 Feb 2014

QuadraMed strikes strategic partnership with Connected Technology Solutions

QuadraMed Corporation is pleased to announce that it has signed an agreement with Connected Technology Solutions, a leading interactive kiosk design and creative marketing company. As part of the agreement, QuadraMed's intuitive point-of-service patient registration solution, QuadraMed MediKiosk, will run on CTS kiosk technology, offering organizations a proven, cost-effective patient registration and check-in solution.

11 Feb 2014

AstraZeneca HealthCare Foundation to award grants to 19 organizations to improve cardiovascular health

The AstraZeneca HealthCare Foundation's Connections for Cardiovascular Health program today announced it will award nearly $3.7 million in grants to 19 nonprofit organizations dedicated to improving cardiovascular health in local communities.

11 Feb 2014

Tamoxifen drug appears to kill fungus associated with deadly brain infection

The drug tamoxifen appears to kill a fungus associated with a deadly brain infection that afflicts HIV/AIDS patients, according to a University of Rochester study published online today by mBio, the journal of the American Society for Microbiology.

11 Feb 2014

Alba Therapeutics reports positive results from Phase IIb trial of larazotide acetate for CeD treatment

Alba Therapeutics Corporation announced today the positive results of their Phase IIb trial evaluating its investigational product, larazotide acetate, a first-in-class tight junction regulator, intended for the treatment of patients with celiac disease (CeD).

11 Feb 2014

Theorem Clinical Research forms strategic alliance with Decision Driver Analytics

Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics that will integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.

11 Feb 2014

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.

11 Feb 2014

Political cartoon: 'The Healthy Alternative?'

Kaiser Health News provides a fresh take on health policy developments with "The Healthy Alternative?" by Jimmy Margulies.

11 Feb 2014

Eternity Healthcare developing saliva-based noninvasive sugar monitoring device

Eternity Healthcare Inc., a medical device and diagnostic company specializing in diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood. The technology utilizes an ultra sensitive sugar monitor and an additional sensor for salivary amylase enzyme activity.

From Medtronic 11 Feb 2014

CareView introduces new CareView Connect Patient Monitoring and Communications module

CareView Communications, Inc., an information technology provider to the healthcare industry, announced today the introduction of its new CareView Connect Patient Monitoring and Communications module.

11 Feb 2014

Medical News

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Self-disorders highly specific to schizophrenia spectrum

U-shaped association between paternal age and bipolar risk

Surgeons now use minimally invasive robotic surgical system for Whipple procedure

New approach for reducing levels of toxic protein fragments associated with Huntington's disease

St. Joseph's Hospital opens new $20 million Heart Institute

Athletic scholarships could lead to long-term health consequences, warns Loyola sports medicine physician

UAB's Continence and Urogynecology Care Clinics reaccredited with Center Of Excellence designation

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

ADM commits $25 million equity investment in Rennovia

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

QuadraMed strikes strategic partnership with Connected Technology Solutions

AstraZeneca HealthCare Foundation to award grants to 19 organizations to improve cardiovascular health

Tamoxifen drug appears to kill fungus associated with deadly brain infection

Alba Therapeutics reports positive results from Phase IIb trial of larazotide acetate for CeD treatment

Theorem Clinical Research forms strategic alliance with Decision Driver Analytics

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Political cartoon: 'The Healthy Alternative?'

Eternity Healthcare developing saliva-based noninvasive sugar monitoring device

CareView introduces new CareView Connect Patient Monitoring and Communications module

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News